Chemicals - Specialty · NYSE
Current Price
$67.28
Intrinsic Value
$64.67
-4.0% margin of safety
As of 2026-07-29, the base-case DCF model estimates the intrinsic value of Eastman Chemical Company (EMN) at $64.67 per share, compared with a market price of $67.28, a margin of safety of -4.0%. The base case assumes 2.9% annual free cash flow growth and a 10.0% discount rate.
Across the sensitivity grid the estimate spans $50.84 to $80.71. Intrinsic value is an estimate built on assumptions, not a fact. A higher discount rate or slower growth pushes the estimate down, while stronger cash flow growth lifts it.
How the DCF works · Recalculate with your own assumptions · What is intrinsic value?
At $67.28, EMN trades about 4.0% above the base-case intrinsic value estimate, a modest premium. By this model the price sits within a normal band, though faster growth than assumed would change the picture.
COMPETITIVE MOAT
↑Specialty Materials Innovation
Eastman's focus on specialty materials, particularly in areas like advanced materials and additives, allows for product differentiation. This innovation drives higher margins and customer loyalty.
↑Molecular Recycling Technology
The company's proprietary molecular recycling technology offers a sustainable advantage. This positions Eastman favorably in a market increasingly demanding eco-friendly solutions.
↑Acquisition Synergies
Strategic acquisitions, like the Jarylec dielectric fluids buyout, expand Eastman's portfolio and strengthen its position in niche markets. This enhances its ability to serve diverse customer needs.
INVESTMENT RISKS
↓Execution of Sustainability Initiatives
The success of Eastman's molecular recycling technology and broader sustainability goals is crucial. Any delays or challenges in scaling these initiatives could impact its long-term growth narrative.
↓Economic Sensitivity of End Markets
Eastman's diverse end markets, including automotive and construction, are sensitive to economic cycles. A significant downturn could reduce demand for its products.
↓Regulatory and Environmental Scrutiny
The chemical industry faces ongoing regulatory and environmental scrutiny. Changes in regulations or increased compliance costs could affect operations and profitability.
Base case
Intrinsic Value
$64.67
Margin of safety
-4.0%
Expected annual return
-0.8%
Base case assumptions: 2.9% annual growth, 10.0% discount rate, 15x exit multiple, 5 year projection. Data as of 2026-07-29.
This base case uses default assumptions and is not financial advice. The intrinsic value changes significantly when the growth rate or discount rate changes. Open the calculator to set your own assumptions and see the full sensitivity range.
Adjust the growth rate, discount rate, and exit multiple to see how the intrinsic value and margin of safety for Eastman Chemical Company respond.
Open DCF Calculator for EMNEastman Chemical Company functions as a worldwide provider of specialized materials. Its Additives & Functional Products division offers a comprehensive range, including hydrocarbon and rosin resins, organic acid-based solutions, and amine-derived building blocks. This segment also provides agricultural chemicals like metam-based soil fumigants, thiram and ziram fungicides, and plant growth regulators. Additional offerings include specialty coalescents, various commodity and specialty solvents, paint additives, specialty polymers, heat transfer and aviation fluids, and rubber additives such as insoluble sulfur and anti-degradants, along with performance resins. These products cater to diverse sectors such as transportation, personal care, wellness, food, agriculture, construction, water treatment, energy, consumables, durables, and electronics. The Advanced Materials segment produces high-performance products including copolyesters, cellulosic biopolymers, cellulose esters, and polyvinyl butyral (PVB) sheets. It further supplies a variety of window and protective films, including those applied aftermarket, for high-value applications in transportation, consumer durables, electronics, building and construction, medical, pharmaceutical, and general consumables markets. Through its Chemical Intermediates segment, Eastman delivers essential chemical building blocks. This encompasses methylamines and their salts, various higher amines and solvents, olefin and acetyl derivatives, ethylene, and both primary phthalate and non-phthalate plasticizers, including specialized non-phthalate alternatives. These intermediates are vital for industrial chemical processes, construction, health and wellness products, and agrochemical formulations. Lastly, the Fibers segment is a significant producer of cellulose acetate tow, triacetin, cellulose acetate flake, acetic acid, and acetic anhydride, primarily for filtration media, notably cigarette filters. It also furnishes natural and solution-dyed acetate yarns for consumables and health and wellness markets, alongside wet-laid nonwoven media, specialty engineered papers, and cellulose acetate fibers for the transportation, industrial, agriculture, mining, and aerospace industries. Eastman Chemical Company was founded in 1920 and is headquartered in Kingsport, Tennessee.
Revenue/Share (TTM)
$75.78
FCF/Share (TTM)
$4.37
ROIC (TTM)
5.4%
ROE (TTM)
6.8%
P/FCF
15.4x
EV/EBITDA
10.5x
FCF Yield
6.47%
Debt/Equity
0.89x
Based on trailing twelve-month data, EMN shows a free cash flow per share of $4.37 and a ROIC of 5.4%, key inputs for stock valuation using the DCF method. The P/FCF ratio of 15.4x and FCF yield of 6.47% are important context metrics when evaluating EMN's stock valuation relative to peers.
Eastman Chemical Company currently generates $4.37 in free cash flow per share. At the current price of $67.28, a DCF model would discount these cash flows at an appropriate WACC and apply a terminal growth rate to arrive at an intrinsic value. The result depends heavily on your growth and discount rate assumptions — a 1% change in WACC typically shifts the fair value estimate by 10-15%. In MiniValuator the model uses a single discount rate that you can edit directly, 10% by default, rather than a computed WACC.
EMN trades at a P/FCF ratio of 15.4x with a free cash flow yield of 6.47%. This P/FCF is in a moderate range. However, whether EMN is truly undervalued requires comparing the DCF intrinsic value to the current market price and evaluating whether the margin of safety is sufficient for your risk tolerance.
To perform a DCF valuation on Eastman Chemical Company: (1) Start with the trailing free cash flow per share ($4.37) as the base, (2) project future FCF growth over 5-10 years based on Chemicals - Specialty industry trends and company fundamentals, (3) apply a discount rate (WACC) reflecting EMN's risk profile — with a debt-to-equity of 0.89x, capital structure is an important factor, and (4) add a terminal value for cash flows beyond the projection period.
DCF (Discounted Cash Flow) estimates what a company is worth today based on its future cash generation. For Eastman Chemical Company, this means projecting how much free cash flow the company will produce over the next 5-10 years, shaped by Chemicals - Specialty trends, then discounting those amounts to today's dollars. EMN's ROIC of 5.4% means the company's return on invested capital sits below the level that typically clears its cost of capital.
WACC (Weighted Average Cost of Capital) is the discount rate in a DCF model — it reflects the minimum return investors require. For EMN, with a debt-to-equity ratio of 0.89x, the capital structure directly influences WACC. A 1% increase in WACC typically reduces the intrinsic value by 10-15%. At an EV/EBITDA of 10.5x, the market's implied discount rate can be reverse-engineered for comparison. In MiniValuator you set this discount rate yourself as a single editable number, 10% by default, instead of computing a formal WACC.
DCF and P/E value EMN with different methods and assumptions, so the two conclusions can differ. Compare the P/E fair value.
Price as of 2026-07-29. Financial data from Financial Modeling Prep (trailing twelve months) · Valuation methodology by Charlie Wang.
This is an estimate, not investment advice.